Leadership : Our Company : GE

Sue Siegel is a GE Corporate Officer and the CEO of healthymagination, GE's $6 billion global commitment to provide better health for more people by lowering costs and increasing access.

Sue is a 25-year industry leader with corporate and venture capital experience in growing companies that bring key enabling technologies to the forefront of biomedical research and healthcare. Prior to joining GE, she was a General Partner at Mohr Davidow Ventures where she led investments spanning enabling technology platforms, molecular diagnostics and digital health, which leveraged the convergence of these disciplines in driving personalized, consumer-driven and information-based healthcare.

Prior to joining Mohr Davidow Ventures, Siegel served as President and Director of Affymetrix, Inc., a publicly traded company that pioneered GeneChip® technology, which propelled the expansion of the genomics field and accelerated the early development of personalized medicine. During her tenure, Siegel grew the company from an early stage company into a global leader with a multi-billion dollar market cap and the gold-standard gene expression platform for biomedical research. Sue's other industry experience includes senior leadership positions with Amersham International, now part of GE Healthcare, E.I. DuPont & Co., Eastman Kodak Co., and Bio-Rad.

Sue served on corporate boards including Affymetrix, Pacific Biosciences, Crescendo Biosciences, RainDance Technologies, Personalis, Analyte Health, Corventis, Navigenics, On-Q-ity, and Didimi.

Sue was named a Henry Crown Fellow of the Aspen Institute and was featured in the bestselling business book: Multipliers: How The Best Leaders Make Everyone Smarter and was recognized as one of "The 100 Most Influential Women in Silicon Valley."

She also served or serves on select advisory boards including:

• the President's Circle of the National Academies;
• the Advisory Council of The Gladstone Institutes, a preeminent biomedical research organization at the University of California, San Francisco;
• the Stanford University Medical School Institute for Immunity, Transplantation, and Infectious Diseases (ITI),
• the Council on Biotechnology Research Innovation, and Public Policy for the Center for Strategic and International Studies (CSIS);
• regional judge for the selection of White House Fellows;, and
• board member on the Silicon Valley Tech Museum.

Sue holds a Bachelor of Science in Biology from the University of Puerto Rico and a Master of Science in Biochemistry from Boston University School of Medicine. She has completed the Stanford Director’s College and executive management coursework at Northwestern University’s Kellogg School of Management and the Harvard Business School.